UK matches:
- Amisulpride 100mg Tablets (SPC)
- Amisulpride 200mg tablets (SPC)
- Amisulpride 400mg tablets (SPC)
- Amisulpride 400mg tablets (SPC)
- Amisulpride 50mg Tablets (SPC)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N05AL05
CAS registry number (Chemical Abstracts Service)
0071675-85-9
Chemical Formula
C17-H27-N3-O4-S
Molecular Weight
369
Therapeutic Categories
Neuroleptic
Antispasmodic agent
Chemical Name
Benzamide, 4-amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxy-
Foreign Names
- Amisulpridum (Latin)
- Amisulprid (German)
- Amisulpride (French)
- Amisulprida (Spanish)
Generic Names
- Amisulpride (OS: BAN, DCF, USAN)
- Aminosultopride (IS)
- AST (IS)
- DAN 2163 (IS)
- Amisulprid (PH: Ph. Eur. 6)
- Amisulpride (PH: BP 2010, Ph. Eur. 6)
- Amisulpridum (PH: Ph. Eur. 6)
Brand Names
- Amiprid
Actavis, Hungary - Amissulprida Alpharma
Alpharma, Portugal - Amisulprid AL
Aliud, Germany - Amisulprid dura
Mylan dura, Germany - Amisulprid Hexal
Hexal, Germany - Amisulprid Lich
Winthrop, Germany - Amisulprid Pliva
Pliva, Slovakia - Amisulprid Sandoz
Sandoz, Germany - Amisulprid Stada
Stada, Germany - Amisulprid TAD
TAD, Germany - Amisulprid Teva
Teva, Germany - Amisulprida Arafarm Group
Arafarma, Spain - Amisulprid-biomo
Biomo, Germany - Amisulpride Actavis
Actavis, France - Amisulpride Arrow
Arrow, France - Amisulpride Biogaran
Biogaran, France - Amisulpride CristerS
CristerS, France - Amisulpride EG
EG, Italy; EG Labo, France; Eurogenerics, Belgium - Amisulpride Mylan
Mylan, Belgium; Mylan, France - Amisulpride Qualimed
Qualimed, France - Amisulpride Ratiopharm
Ratiopharm, France; Ratiopharm, Slovakia - Amisulpride RPG
RPG, France - Amisulpride Sandoz
Sandoz, Australia; Sandoz, France - Amisulpride Teva
Teva Santé, France - Amisulpride Winthrop
Sanofi-Aventis, Australia; Sanofi-Aventis, Switzerland; Sanofi-Aventis, France - Amisulpride Zydus
Zydus, France - Amisulprid-Hormosan
Hormosan, Germany - Amisulprid-neuraxpharm
Neuraxpharm, Germany - Amisulprid-ratiopharm
Ratiopharm, Germany; Ratiopharm, Hungary - Amitrex
Sanofi-Aventis, Hungary; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal - Deniban
Sanofi-Aventis, Colombia; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, Italy; Sanofi-Aventis, Peru - Enorden
Finadiet, Argentina - Goldalian
Aeon, Greece - Isofredil
Vocate, Greece - Matil
Pharmanel, Greece - Nodasic
Rafarm, Greece - Socian
Sanofi-Aventis, Chile; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal; Sanofi-Synthelabo, Brazil - Solian
Sanofi Aventis, Tunisia; Sanofi Winthrop, Bulgaria; Sanofi-Aventis, Austria; Sanofi-Aventis, Australia; Sanofi-Aventis, Belgium; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, Germany; Sanofi-Aventis, Denmark; Sanofi-Aventis, Estonia; Sanofi-Aventis, France; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Croatia (Hrvatska); Sanofi-Aventis, Hungary; Sanofi-Aventis, Ireland; Sanofi-Aventis, Israel; Sanofi-Aventis, Italy; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Latvia; Sanofi-Aventis, Mexico; Sanofi-Aventis, Norway; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Philippines; Sanofi-Aventis, Poland; Sanofi-Aventis, Russian Federation; Sanofi-Aventis, Singapore; Sanofi-Aventis, Slovakia; Sanofi-Aventis, Turkey; Sanofi-Aventis, Taiwan; Sanofi-Aventis, Vietnam; Sanofi-Aventis, South Africa; Sanofi-Aventis S.A., Spain; Sanofi-Synthelabo, Bulgaria; Sanofi-Synthelabo, Greece; Sanofi-Synthelabo, Iceland; Sanofi-Synthelabo, Luxembourg; Sanofi-Synthelabo, Romania; Sanofi-Synthelabo, Slovenia - Sulamid
Baldacci, Italy - Sulprid
Teva, Bulgaria - Zolen
Galpharma, Tunisia - Zoloser
Verisfield, Greece
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| SPC | Summary of Product Characteristics (UK) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment